Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 ,inter alia, to consider and approve To Consider and Approve the audited standalone financial results for the quarter and year ended March 31, 2025 along with limited review report of the auditors and other items.